Cellectis (CLLS) Tax Provisions (2023)

Cellectis' (CLLS) quarterly Tax Provisions came in at $6000.0 in Q4 2023, down 94.39% quarter-over-quarter from $107000.0 in Q3 2023.

Cellectis (CLLS) Tax Provisions (2023) Analysis & Trends

Cellectis' Tax Provisions history runs 1 years deep, the most recent figure standing at $6000.0 for Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	125,146.46
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-859,000.00
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	31.86 Mn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	221.50 Mn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	104.00 Mn
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-60.00 Mn
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Cellectis	285.50 Mn	99.83 Mn	-	-

Download Data